GlassScriptPhysician profile
Nam D Tran
NPI 1134338569
$46,503.05
in general payments reported to CMS, 2019-2025
17 companies · $21K in 2025
The $21K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $2,528 · 2021: $13K · 2022: $6,130 · 2023: $3,261 · 2024: $291 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Consulting Fee: $3,100 · Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,926.59 |
| Consulting Fee | $3,100.00 |
| Food and Beverage | $705.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carbofix Spine INC | $20,929.19 | 2024-2025 | Carboclear Hybrid Pedicle Screw System, Carboclear X Pedicle Screw System |
| Medtronic, INC. | $13,180.18 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $8,692.50 | 2022-2023 | Koselugo |
| Novocure INC. | $2,500.00 | 2020 | |
| Globus Medical, INC. | $238.29 | 2025 | Excelsius Gps, Alif, Xlif |
| Stryker Corporation | $207.40 | 2024 | Scopis Ent |
| Foundation Medicine, INC. | $192.68 | 2021 | |
| Alphatec Spine, INC | $157.12 | 2021 | |
| Depuy Synthes Sales INC. | $101.01 | 2019 | |
| Axogen | $95.97 | 2023 | Avance Nerve Graft |
| Abbott Laboratories | $61.86 | 2019 | |
| Merit Medical Systems INC | $44.40 | 2024 | Stabilit System, Star Tumor Ablation System |
| Biomerieux INC | $34.00 | 2025 | |
| Icotec Medical INC. | $28.16 | 2020 | |
| Sk Life Science, INC. | $22.20 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Welireg |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.